Botta G - Search Results

1

The role of mitochondria in pharmacotoxicology: a reevaluation of an old, newly emerging topic.

Scatena R, Bottoni P, Botta G, Martorana GE, Giardina B. Scatena R, et al. Among authors: botta g. Am J Physiol Cell Physiol. 2007 Jul;293(1):C12-21. doi: 10.1152/ajpcell.00314.2006. Epub 2007 May 2. Am J Physiol Cell Physiol. 2007. PMID: 17475665 Free article. Review.

2

An update on pharmacological approaches to neurodegenerative diseases.

Scatena R, Martorana GE, Bottoni P, Botta G, Pastore P, Giardina B. Scatena R, et al. Among authors: botta g. Expert Opin Investig Drugs. 2007 Jan;16(1):59-72. doi: 10.1517/13543784.16.1.59. Expert Opin Investig Drugs. 2007. PMID: 17155854 Review.

3

Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology.

Scatena R, Bottoni P, Martorana GE, Vincenzoni F, Botta G, Pastore P, Giardina B. Scatena R, et al. Among authors: botta g. Eur J Pharmacol. 2007 Jul 12;567(1-2):50-8. doi: 10.1016/j.ejphar.2007.04.017. Epub 2007 Apr 22. Eur J Pharmacol. 2007. PMID: 17499714

4

Novel pyrrole-containing histone deacetylase inhibitors endowed with cytodifferentiation activity.

Mai A, Valente S, Rotili D, Massa S, Botta G, Brosch G, Miceli M, Nebbioso A, Altucci L. Mai A, et al. Among authors: botta g. Int J Biochem Cell Biol. 2007;39(7-8):1510-22. doi: 10.1016/j.biocel.2007.03.020. Epub 2007 Apr 4. Int J Biochem Cell Biol. 2007. PMID: 17482499

5

ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.

Torlone E, Rambotti AM, Perriello G, Botta G, Santeusanio F, Brunetti P, Bolli GB. Torlone E, et al. Among authors: botta g. Diabetologia. 1991 Feb;34(2):119-25. doi: 10.1007/BF00500383. Diabetologia. 1991. PMID: 2065846 Clinical Trial.

6

Generation of RNA molecules by a base-catalysed click-like reaction.

Costanzo G, Saladino R, Botta G, Giorgi A, Scipioni A, Pino S, Di Mauro E. Costanzo G, et al. Among authors: botta g. Chembiochem. 2012 May 7;13(7):999-1008. doi: 10.1002/cbic.201200068. Epub 2012 Mar 30. Chembiochem. 2012. PMID: 22474011

7

Current Advances in L-DOPA and DOPA-Peptidomimetics: Chemistry, Applications and Biological Activity.

Bizzarri BM, Tortolini S, Rotelli L, Botta G, Saladino R. Bizzarri BM, et al. Among authors: botta g. Curr Med Chem. 2015;22(36):4138-65. doi: 10.2174/0929867322666150625095748. Curr Med Chem. 2015. PMID: 26112144 Review.

8

Class II-selective histone deacetylase inhibitors. Part 2: alignment-independent GRIND 3-D QSAR, homology and docking studies.

Ragno R, Simeoni S, Rotili D, Caroli A, Botta G, Brosch G, Massa S, Mai A. Ragno R, et al. Among authors: botta g. Eur J Med Chem. 2008 Mar;43(3):621-32. doi: 10.1016/j.ejmech.2007.05.004. Epub 2007 May 27. Eur J Med Chem. 2008. PMID: 17698257

9

Benzodeazaoxaflavins as sirtuin inhibitors with antiproliferative properties in cancer stem cells.

Rotili D, Tarantino D, Carafa V, Paolini C, Schemies J, Jung M, Botta G, Di Maro S, Novellino E, Steinkühler C, De Maria R, Gallinari P, Altucci L, Mai A. Rotili D, et al. Among authors: botta g. J Med Chem. 2012 Sep 27;55(18):8193-7. doi: 10.1021/jm301115r. Epub 2012 Sep 7. J Med Chem. 2012. PMID: 22931526

10

Synthesis and biological properties of novel, uracil-containing histone deacetylase inhibitors.

Mai A, Massa S, Rotili D, Simeoni S, Ragno R, Botta G, Nebbioso A, Miceli M, Altucci L, Brosch G. Mai A, et al. Among authors: botta g. J Med Chem. 2006 Oct 5;49(20):6046-56. doi: 10.1021/jm0605536. J Med Chem. 2006. PMID: 17004718

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters